These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

189 related articles for article (PubMed ID: 7701088)

  • 21. Tourette's syndrome is associated with an increased risk of traumatic brain injury: A nationwide population-based cohort study.
    Chen SF; Su YC; Wang LY; Hsu CY; Shen YC
    Parkinsonism Relat Disord; 2019 Jun; 63():88-93. PubMed ID: 30833232
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Tourette's syndrome in patients referred for allergy evaluation.
    Kim H; Moote W; Mazza J
    Ann Allergy Asthma Immunol; 1997 Oct; 79(4):347-9. PubMed ID: 9357381
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The behavioral spectrum of Gilles de la Tourette syndrome.
    Cavanna AE; Servo S; Monaco F; Robertson MM
    J Neuropsychiatry Clin Neurosci; 2009; 21(1):13-23. PubMed ID: 19359447
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Emerging treatments for Tourette's disorder.
    Bloch MH
    Curr Psychiatry Rep; 2008 Aug; 10(4):323-30. PubMed ID: 18627671
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Whole blood serotonin and tryptophan levels in Tourette's disorder: effects of acute and chronic clonidine treatment.
    Leckman JF; Anderson GM; Cohen DJ; Ort S; Harcherik DF; Hoder EL; Shaywitz BA
    Life Sci; 1984 Dec; 35(25):2497-503. PubMed ID: 6595491
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Depression and dysphoria in adult and adolescent patients with Tourette's disorder treated with risperidone.
    Margolese HC; Annable L; Dion Y
    J Clin Psychiatry; 2002 Nov; 63(11):1040-4. PubMed ID: 12444819
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Decreased motor inhibition in Tourette's disorder: evidence from transcranial magnetic stimulation.
    Ziemann U; Paulus W; Rothenberger A
    Am J Psychiatry; 1997 Sep; 154(9):1277-84. PubMed ID: 9286189
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Onset of Gilles de la Tourette's syndrome before 1 year of age.
    Burd L; Kerbeshian J
    Am J Psychiatry; 1987 Aug; 144(8):1066-7. PubMed ID: 3474905
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Recognition and management of Tourette's syndrome and tic disorders.
    Bagheri MM; Kerbeshian J; Burd L
    Am Fam Physician; 1999 Apr; 59(8):2263-72, 2274. PubMed ID: 10221310
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Tardive Tourette's syndrome treated with clonidine and mesoridazine.
    Munetz MR; Slawsky RC; Neil JF
    Psychosomatics; 1985 Mar; 26(3):254, 257. PubMed ID: 2859628
    [No Abstract]   [Full Text] [Related]  

  • 31. Tourette's syndrome: update.
    Freeman RD; Connolly JE; Baird PA
    Can Med Assoc J; 1984 Jun; 130(12):1554-7. PubMed ID: 6587930
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Tourette's disorder and related problems: a review and update.
    Coffey BJ; Miguel EC; Savage CR; Rauch SL
    Harv Rev Psychiatry; 1994; 2(3):121-32. PubMed ID: 9384893
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The relationship between types and severity of repetitive behaviors in Gilles de la Tourette's disorder and obsessive-compulsive disorder.
    Cath DC; Spinhoven P; van de Wetering BJ; Hoogduin CA; Landman AD; van Woerkom TC; Roos RA; Rooijmans HG
    J Clin Psychiatry; 2000 Jul; 61(7):505-13. PubMed ID: 10937609
    [TBL] [Abstract][Full Text] [Related]  

  • 34. B lymphocyte antigen D8/17: a peripheral marker for childhood-onset obsessive-compulsive disorder and Tourette's syndrome?
    Murphy TK; Goodman WK; Fudge MW; Williams RC; Ayoub EM; Dalal M; Lewis MH; Zabriskie JB
    Am J Psychiatry; 1997 Mar; 154(3):402-7. PubMed ID: 9054790
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Tourette's syndrome: old syndrome, new insights and new treatment.
    Bhidayasiri R
    J Med Assoc Thai; 2005 Sep; 88 Suppl 4():S339-47. PubMed ID: 16623052
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A developmental fMRI study of self-regulatory control in Tourette's syndrome.
    Marsh R; Zhu H; Wang Z; Skudlarski P; Peterson BS
    Am J Psychiatry; 2007 Jun; 164(6):955-66. PubMed ID: 17541057
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Pharmacokinetics of pimozide in adults and children with Tourette's syndrome.
    Sallee FR; Pollock BG; Stiller RL; Stull S; Everett G; Perel JM
    J Clin Pharmacol; 1987 Oct; 27(10):776-81. PubMed ID: 3480904
    [TBL] [Abstract][Full Text] [Related]  

  • 38. PET studies of the presynaptic and postsynaptic dopaminergic system in Tourette's syndrome.
    Turjanski N; Sawle GV; Playford ED; Weeks R; Lammerstma AA; Lees AJ; Brooks DJ
    J Neurol Neurosurg Psychiatry; 1994 Jun; 57(6):688-92. PubMed ID: 7911827
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Worsening of Tourette's disorder due to neuroleptic-induced akathisia.
    Weiden P; Bruun R
    Am J Psychiatry; 1987 Apr; 144(4):504-5. PubMed ID: 2882696
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Treatment of Gilles de la Tourette's syndrome with clonidine and neuroleptics.
    Shapiro AK; Shapiro E; Eisenkraft GJ
    Arch Gen Psychiatry; 1983 Nov; 40(11):1235-40. PubMed ID: 6139100
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.